We describe a case of a young man with metastatic cancer whose predominant symptom burden was pain caused by both recurrence of his primary sarcoma and the metastatic deposits in different bones of ...

Kimberly Nix in the hospital. Three years after being diagnosed with metastatic sarcoma, Dr. Kimberley Nix died on Wednesday, May 8. The 31-year-old from Calgary, Alberta, first gained attention in ...

Kimberley Nix was a 28-year-old medical resident when she was diagnosed with metastatic sarcoma. Today, she continues her studies while sharing her journey on social media Stephanie Sengwe is a pop ...

Sandra D’Angelo, MD, talked about a study examining the role of tumor-infiltrating lymphocyte, or TIL, in metastatic sarcoma presented at the Connective Tissue Oncology Society Annual Meeting in a ...

Neoadjuvant treatment evaluation in soft tissue sarcomas (STS): Looking for news in radiologic and pathologic response. Background: Uterine leiomyosarcoma (LMS) is a rare disease and, when recurs or ...

A novel intratumoral treatment was administered to the first patient in a phase 3 trial for certain patients with metastatic soft tissue sarcoma. A phase 3 trial for patients with metastatic soft ...

Ewing sarcoma is a malignant type of bone tumor, meaning it is a form of cancer that spreads. According to a 2024 review, Ewing sarcoma is the second most common primary cancerous bone tumor. It ...

Here, we report the case of a patient with metastatic UPS of the chest wall successfully treated with an anti–PD-L1 ICI at the Clinical Trial Unit of the Hospital Clinic of Barcelona (HCB), who ...

Soft tissue sarcomas rarely metastasize to the heart, with cardiac involvement seen in less than 0.03% of cases. Metastatic heart disease presents diagnostic challenges due to nonspecific symptoms, ...

Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found that under a quarter of children with multi-metastatic Ewing sarcoma ...

Intensity Therapeutics’ stock has risen nearly 400% after its oncology candidate showed high overall survival (OS) and disease control. In the Phase I/II trial (NCT03058289), INT230-6 showed a disease ...

Kimberly Nix was well into her journey to become a doctor when life threw a wrench at her: She was diagnosed with metastatic sarcoma in 2021. At the time, Dr. Nix was only 28 years old and in the ...